Press Releases April 29, 2026 04:15 PM

Plexus Announces Fiscal Second Quarter Financial Results

Plexus Corp. Reports Record Fiscal Q2 2026 Revenue and Raises Q3 Guidance Amid Strong Manufacturing Wins Across Key Sectors

By Hana Yamamoto PLXS
Plexus Announces Fiscal Second Quarter Financial Results
PLXS

Plexus Corp. announced record fiscal Q2 2026 revenue of $1.164 billion, surpassing guidance with 19% year-over-year growth. The company reported GAAP diluted EPS of $1.82 and non-GAAP EPS of $2.05. Plexus won 30 new manufacturing programs amounting to $355 million in annualized revenue and generated $16 million in free cash flow during the quarter. For fiscal Q3 2026, Plexus provided revenue guidance between $1.2 billion and $1.25 billion, with expected non-GAAP EPS of $2.02 to $2.18. Management highlighted strong performance driven by aerospace/defense, healthcare/life sciences, and industrial sectors and maintained a focus on operational efficiency.

Key Points

  • Record fiscal Q2 2026 revenue of $1.164 billion, exceeding guidance and up 19% year-over-year.
  • Won 30 manufacturing programs worth $355 million in annualized revenue across aerospace/defense, healthcare/life sciences, and industrial sectors.
  • Generated $16 million free cash flow in Q2 with improved cash cycle and strong ROIC of 13.8%, well above cost of capital.
  • Raised fiscal Q3 2026 revenue guidance and reaffirmed mid-teens revenue growth outlook for fiscal 2026 driven by robust operational execution.

NEENAH, WI, April 29, 2026 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal second quarter ended April 4, 2026, and guidance for our fiscal third quarter ending July 4, 2026.

  • Reports record fiscal second quarter 2026 revenue of $1.164 billion, GAAP operating margin of 5.3% and GAAP diluted EPS of $1.82.
  • Reports fiscal second quarter 2026 non-GAAP operating margin of 6.0% and non-GAAP diluted EPS of $2.05, excluding $0.23 of stock-based compensation expense.
  • Initiates fiscal third quarter 2026 revenue guidance of $1.200 billion to $1.250 billion with GAAP diluted EPS of $1.25 to $1.41, including $0.77 of stock-based compensation expense. Fiscal third quarter non-GAAP EPS guidance of $2.02 to $2.18 excludes stock-based compensation expense.
  Three Months Ended  Apr 4, 2026 Apr 4, 2026 Jul 4, 2026  Q2F26 Results Q2F26 Guidance Q3F26 GuidanceSummary GAAP Items     Revenue (in billions)$1.164  $1.110 to $1.150 $1.200 to $1.250Operating margin 5.3%  4.9% to 5.3% 4.1% to 4.5%Diluted EPS$1.82  $1.53 to $1.68 $1.25 to $1.41       Summary Non-GAAP Items (1)     Adjusted operating margin (2) 6.0%  5.6% to 6.0% 5.9% to 6.3%Adjusted EPS (3)$2.05  $1.80 to $1.95 $2.02 to $2.18Return on invested capital (ROIC) 13.8%     Economic return 4.8%            (1) Refer to Non-GAAP Supplemental Information tables for additional information regarding non-GAAP financial measures.
(2) Excludes stock-based compensation expense of approximately 70 bps for Q2F26 results and Q2F26 guidance and 180 bps for Q3F26 guidance.
(3)Excludes stock-based compensation expense, net of tax, of $0.23 for Q2F26 results, $0.27 for Q2F26 guidance and $0.77 for Q3F26 guidance.

Fiscal Second Quarter 2026 Information

  • Won 30 manufacturing programs during the quarter representing a record $355 million in annualized revenue when fully ramped into production.
  • Generated free cash flow of $16.0 million.
  • Purchased $20.6 million of our shares at an average price of $189.22 per share under our 2026 Share Repurchase Program, leaving $42.0 million available under our existing $100.0 million authorization.

Todd Kelsey, President and Chief Executive Officer, commented, “Our momentum is accelerating broadly. For the fiscal second quarter, we increased revenue significantly year-over-year, delivered record manufacturing wins, expanded our efficiency efforts and generated robust profitability. We produced record revenue of $1.164 billion, which exceeded our guidance range and increased 19% year-over-year with significant contributions from all market sectors. In addition, non-GAAP operating margin of 6.0% met the high end of guidance, while non-GAAP EPS of $2.05 exceeded guidance.”

Mr. Kelsey added, “Our go-to-market team achieved record quarterly manufacturing wins of $355 million in annualized revenue. This included broad-based programs in aerospace and defense, expanded relationships and share gains in surgical and imaging platforms, a new engagement in data center power solutions and continued share gains in semiconductor capital equipment. While achieving this tremendous wins result, we also expanded our funnel of qualified manufacturing opportunities.”

Patrick Jermain, Executive Vice President and Chief Financial Officer, commented, “Our fiscal second quarter cash cycle of 64 days represented a better-than-expected sequential improvement of 5 days, the benefit of continued progress on working capital initiatives and stronger-than-guided revenue. Our favorable cash cycle combined with our strong operating performance produced a fiscal second quarter return on invested capital of 13.8%, which exceeded our cost of capital by 480 basis points. We also delivered $16 million in free cash flow for the fiscal second quarter, a result that surpassed our projections. We are strategically increasing working capital investments in support of accelerating revenue growth, with an expectation to maintain cash cycle days consistent with our recent performance. As a result, we now expect to generate fiscal 2026 free cash flow in the range of $50 to $75 million.”

Mr. Kelsey continued, “We anticipate continued strong performance for our fiscal third quarter from program ramps, improved end-market demand and our sustained focus on operational efficiency. We are guiding revenue of $1.200 to $1.250 billion, representing 5% sequential and 20% year-over-year growth at the midpoint, non-GAAP operating margin of 5.9% to 6.3% and non-GAAP EPS of $2.02 to $2.18.”

Mr. Kelsey concluded, “Plexus’ consistent focus on redefining excellence through our unmatched quality and delivery is shaping our decision-making and sustaining our tremendous momentum. Leveraging this momentum, and our excellent financial performance year to date, we now expect Plexus to deliver mid-teens or greater fiscal 2026 revenue growth, with robust operating performance.”

Quarterly ComparisonThree Months Ended(in thousands, except EPS)Apr 4, 2026 Jan 3, 2026 Mar 29, 2025Revenue$1,163,757  $1,069,852  $980,170 Gross profit 119,176   106,138   97,751 Operating income 61,837   54,464   48,791 Net income 49,809   41,182   39,073 Diluted EPS$1.82  $1.51  $1.41       Gross margin 10.2%   9.9%   10.0%Operating margin 5.3%   5.1%   5.0%      ROIC (1) 13.8%   13.2%   13.7%Economic return (1) 4.8%   4.2%   4.8%      (1) Refer to Non-GAAP Supplemental Information tables for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return.

Business Segment and Market Sector Revenue

Plexus measures operational performance and allocates resources on a geographic segment basis. Plexus also reports revenue based on the market sector breakout set forth in the table below, which reflects Plexus’ market sector focused strategy. Top 10 customers comprised 54% of revenue during the second quarter of fiscal 2026. This is up 2 percentage points from the first quarter of fiscal 2026 and up 3 percentage points from the second quarter of fiscal 2025.

Business Segments ($ in millions)Three Months Ended  Apr 4, 2026 Jan 3, 2026 Mar 29, 2025Americas$397  $345  $295 Asia-Pacific 652   612   587 Europe, Middle East and Africa 116   118   103 Elimination of inter-segment sales (1)   (5)   (5) Total Revenue$1,164  $1,070  $980        


Market Sectors ($ in millions)Three Months Ended Apr 4, 2026 Jan 3, 2026 Mar 29, 2025Aerospace/Defense$21218%  $17817%  $17218% Healthcare/Life Sciences 47341%   46643%   41142% Industrial 47941%   42640%   39740% Total Revenue$1,164  $1,070  $980 

Non-GAAP Supplemental Information

Plexus provides non-GAAP supplemental information, such as ROIC, economic return and free cash flow, because such measures are used for internal management goals and decision-making, and because they provide management and investors with additional insight into financial performance. In addition, management uses these and other non-GAAP measures, such as adjusted operating income, adjusted operating margin, adjusted net income and adjusted diluted EPS, to provide a better understanding of core performance for purposes of period-to-period comparisons. Plexus believes that these measures are also useful to investors because they provide further insight by eliminating the effect of non-recurring items that are not reflective of continuing operations. For additional information on non-GAAP measures, please refer to the attached Non-GAAP Supplemental Information tables.

ROIC and Economic Return

ROIC for the second quarter of fiscal 2026 was 13.8%. Plexus defines ROIC as tax-effected annualized adjusted operating income divided by average invested capital over a three-quarter period for the second fiscal quarter. Invested capital is defined as equity plus debt and operating lease obligations, less cash and cash equivalents. Plexus' weighted average cost of capital for fiscal 2026 is 9.0%. ROIC for the second quarter of fiscal 2026 less Plexus’ weighted average cost of capital resulted in an economic return of 4.8%.

Free Cash Flow

Plexus defines free cash flow as cash flows provided by operations less capital expenditures. For the three months ended April 4, 2026, cash flows provided by operations was $28.5 million and capital expenditures were $12.5 million, which resulted in free cash flow of $16.0 million.

Cash Cycle DaysThree Months Ended  Apr 4, 2026 Jan 3, 2026 Mar 29, 2025Days in Accounts Receivable55  58  57 Days in Contract Assets12  13  12 Days in Inventory120  124  132 Days in Accounts Payable(74)  (71)  (70) Days in Advanced Payments(49)  (55)  (63) Annualized Cash Cycle (1)64  69  68        (1) Plexus calculates cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in advanced payments.

Conference Call and Webcast Information

What:   Plexus Fiscal 2026 Q2 Earnings Conference Call and WebcastWhen:   Thursday, April 30, 2026 at 8:30 a.m. Eastern TimeWhere:   Participants are encouraged to join the live webcast at the investor relations section of the Plexus website, plexus.com. Participants can also join utilizing the links below:

Webcast link:
https://events.q4inc.com/attendee/177402160Replay:   The webcast will be archived on the Plexus website and will be available as on-demand for 12 months

Investor and Media Contact
Shawn Harrison
+1.920.969.6325
[email protected]

About Plexus
At Plexus, we help create the products that build a better world. Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex products in demanding regulatory environments. From life-saving medical devices and mission-critical aerospace and defense products to industrial automation systems and semiconductor capital equipment, our innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. We provide these solutions to market-leading as well as disruptive global companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors, supported by a global team of over 20,000 members across our 27 facilities. For more information about Plexus, visit our website at www.plexus.com.

Safe Harbor and Fair Disclosure Statement
The statements contained in this press release that are guidance or which are not historical facts (such as statements in the future tense and statements including believe, expect, intend, plan, anticipate, goal, target and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include the effects of tariffs, trade disputes, trade agreements and other trade protection measures; the effects of shortages, delays and price fluctuations in obtaining components as a result of economic cycles, capacity constraints, natural disasters or otherwise; the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs; the particular risks relative to new or recent customers, programs or services, which risks include customer and other delays, start-up costs, potential inability to execute, the establishment of appropriate engagement terms, and the lack of a track record of order volume and timing; the risk that new program wins and/or customer demand may not result in the expected revenue or profitability; the lack of visibility of future orders, particularly in view of changing economic conditions; the economic performance of the industries, sectors and customers we serve; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers, maintain our current customers and deliver product on a timely basis; the risks of concentration of work for certain customers; the effects of start-up costs of new programs and facilities or the costs associated with winding down programs or the closure or consolidation of facilities; possible unexpected costs and operating disruption in transitioning programs, including transitions between Company facilities; the risks associated with excess and obsolete inventory, including the risk that inventory purchased on behalf of our customers may not be consumed or otherwise paid for by the customer, resulting in an inventory write-off; the fact that customer orders may not lead to long-term relationships; our ability to manage successfully and execute a complex business model characterized by high product mix and demanding quality, regulatory, and other requirements; the outcome of litigation and regulatory investigations and proceedings, including the results of any challenges with regard to such outcomes; the ability to realize anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as compared to actual expenses; risks related to information technology systems and data security; increasing regulatory and compliance requirements; any tax law changes and related foreign jurisdiction tax developments; current or potential future barriers to the repatriation of funds that are currently held outside of the United States as a result of actions taken by other countries or otherwise; the potential effects of jurisdictional results on our taxes, tax rates, and our ability to use deferred tax assets and net operating losses; the weakness of the economy regionally or globally; the effect of changes in the pricing and margins of our services; raw materials and component cost fluctuations; the potential effect of fluctuations in the value of the currencies in which we transact business; the effects of changes in economic conditions, political conditions and regulatory matters in the United States and in the other countries in which we do business; the potential effect of other events outside our control, such as the conflict between Russia and Ukraine, conflict in the Middle East (including in Iran), escalating tensions between China and Taiwan or China and the United States, tensions in or amongst countries in which we operate or transact business, changes in energy prices, terrorism, global health epidemics and weather events; the impact of increased competition; an inability to successfully manage human capital; changes in financial accounting standards; and other risks detailed herein and in our other Securities and Exchange Commission filings, particularly in Risk Factors contained in our fiscal 2025 Form 10-K.

PLEXUS CORP. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(in thousands, except per share data)(unaudited)       Three Months Ended Six Months Ended Apr 4, Mar 29, Apr 4, Mar 29, 2026
 2025
 2026
 2025
Net sales$1,163,757  $980,170  $2,233,609  $1,956,292 Cost of sales 1,044,581   882,419   2,008,295   1,757,849 Gross profit 119,176   97,751   225,314   198,443 Operating expenses:       Selling and administrative expenses 57,339   48,960   109,013   98,109 Restructuring and other charges, net —   —   —   4,683 Operating income 61,837   48,791   116,301   95,651 Other income (expense):       Interest expense (3,422)   (3,137)   (6,310)   (6,691) Interest income 812   871   1,796   2,105 Miscellaneous, net (1,350)   (1,502)   (2,878)   (2,548) Income before income taxes 57,877   45,023   108,909   88,517 Income tax expense 8,068   5,950   17,918   12,177 Net income$49,809  $39,073  $90,991  $76,340 Earnings per share:       Basic$1.86  $1.44  $3.40  $2.82 Diluted$1.82  $1.41  $3.32  $2.75 Weighted average shares outstanding:       Basic 26,757   27,109   26,762   27,098 Diluted 27,310   27,662   27,369   27,726 


PLEXUS CORP. AND SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE SHEETS(in thousands)(unaudited) Apr 4, Sep 27,  2026   2025 ASSETS   Current assets:   Cash and cash equivalents$303,133  $306,464 Restricted cash 48   294 Accounts receivable 702,339   656,573 Contract assets 160,382   150,654 Inventories 1,373,732   1,229,839 Prepaid expenses and other 97,569   54,969 Total current assets 2,637,203   2,398,793 Property, plant and equipment, net 535,171   546,052 Operating lease right-of-use assets 68,632   72,863 Deferred income taxes 91,663   91,349 Other assets 28,300   28,053 Total non-current assets 723,766   738,317 Total assets$3,360,969  $3,137,110     LIABILITIES AND SHAREHOLDERS’ EQUITY   Current liabilities:   Current portion of long-term debt and finance lease obligations$143,112  $45,793 Accounts payable 851,909   726,597 Advanced payments from customers 565,346   575,850 Accrued salaries and wages 90,924   109,076 Other accrued liabilities 60,989   61,367 Total current liabilities 1,712,280   1,518,683 Long-term debt and finance lease obligations, net of current portion 91,034   91,987 Long-term operating lease liabilities 25,769   29,422 Deferred income taxes 5,155   6,000 Other liabilities 36,931   36,430 Total non-current liabilities 158,889   163,839 Total liabilities 1,871,169   1,682,522 Shareholders’ equity:   Common stock 549   547 Additional paid-in-capital 689,909   695,653 Common stock held in treasury (1,298,881)   (1,255,451) Retained earnings 2,087,019   1,996,028 Accumulated other comprehensive income 11,204   17,811 Total shareholders’ equity 1,489,800   1,454,588 Total liabilities and shareholders’ equity$3,360,969  $3,137,110      


PLEXUS CORP. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(in thousands)(unaudited)     Six Months Ended Apr 4, Mar 29, 2026
 2025
Cash flows from operating activities   Net income$90,991  $76,340 Adjustments to reconcile net income to net cash flows from operating activities:   Depreciation and amortization 38,493   38,925 Share-based compensation expense and related charges 15,685   14,771 Other, net (88)   (6,125) Changes in operating assets and liabilities, excluding impacts of currency:   Accounts receivable (47,335)   9,100 Contract assets (9,770)   (15,624) Inventories (145,413)   25,310 Other current and non-current assets (45,965)   (240) Accrued income taxes payable (7,006)   (12,390) Accounts payable 146,673   70,624 Advanced payments from customers (9,945)   (95,297) Other current and non-current liabilities (13,240)   (15,064) Cash flows provided by operating activities 13,080   90,330 Cash flows from investing activities   Payments for property, plant and equipment (47,650)   (46,726) Other, net (29)   (28) Cash flows used in investing activities (47,679)   (46,754) Cash flows from financing activities   Borrowings under debt agreements 384,500   127,000 Payments on debt and finance lease obligations (289,863)   (165,202) Repurchases of common stock (43,430)   (25,366) Payments related to tax withholding for share-based compensation (21,426)   (14,527) Cash flows provided by (used in) financing activities 29,781   (78,095) Effect of exchange rate changes on cash and cash equivalents 1,241   (2,381) Net decrease in cash and cash equivalents and restricted cash (3,577)   (36,900) Cash and cash equivalents and restricted cash:   Beginning of period 306,758   347,462 End of period$303,181  $310,562      


PLEXUS CORP. AND SUBSIDIARIESNON-GAAP SUPPLEMENTAL INFORMATION Table 1(in thousands, except per share data)(unaudited)             Three Months Ended Six Months Ended  Apr 4, Jan 3, Mar 29, Apr 4, Mar 29,  2026
 2026
 2025
 2026
 2025
Operating income, as reported$61,837  $54,464  $48,791  $116,301  $95,651 Operating margin, as reported 5.3%   5.1%   5.0%   5.2%   4.9%            Non-GAAP adjustments:         Restructuring costs (1) —   —   —   —   4,683 Stock-based compensation 7,922   7,765   7,132   15,687   14,122 Non-GAAP operating income$69,759  $62,229  $55,923  $131,988  $114,456 Non-GAAP operating margin 6.0%   5.8%   5.7%   5.9%   5.9%            Net income, as reported$49,809  $41,182  $39,073  $90,991  $76,340            Non-GAAP adjustments:         Restructuring costs, net of tax (1) —   —   —   —   4,191 Stock-based compensation, net of tax 6,055   7,377   6,775   13,432   13,415 Adjusted net income$55,864  $48,559  $45,848  $104,423  $93,946            Diluted earnings per share, as reported$1.82  $1.51  $1.41  $3.32  $2.75            Non-GAAP per share adjustments:         Restructuring costs, net of tax (1) —   —   —   —   0.15 Stock-based compensation, net of tax 0.23   0.27   0.25   0.50   0.49 Adjusted diluted earnings per share$2.05  $1.78  $1.66  $3.82  $3.39            (1) During the six months ended March 29, 2025, restructuring costs of $4.7 million, or $4.2 million net of taxes, were incurred primarily for employee severance costs associated with a reduction in the Company’s workforce in the EMEA and AMER regions.
                                            


PLEXUS CORP. AND SUBSIDIARIESNON-GAAP SUPPLEMENTAL INFORMATION Table 2(in thousands)(unaudited)      ROIC and Economic Return CalculationsSix Months Ended Three Months Ended Six Months Ended Apr 4, Jan 3, Mar 29, 2026
 2026
 2025
Operating income, as reported $116,301   $54,464   $95,651 Restructuring and other charges, net+ —  + —  + 4,683 Adjusted operating income $116,301   $54,464   $100,334  x 2  x 4  x 2          Adjusted annualized operating income $232,602   $217,856   $200,668 Adjusted effective tax ratex 17%  x 17%  x 13% Tax impact  39,542    37,036    26,087 Adjusted operating income (tax-effected) $193,060   $180,820   $174,581          Average invested capital÷$1,401,134  ÷$1,374,532  ÷$1,276,742 ROIC  13.8%    13.2%    13.7% Weighted average cost of capital- 9.0%  - 9.0%  - 8.9% Economic return  4.8%    4.2%    4.8% 


               Average Invested Capital CalculationsApr 4, Jan 3, Sep 27, Jun 28, Mar 29, Dec 28, Sep 28,  2026
 2026
 2025
 2025
 2025
 2024
 2024
 Equity$1,489,800  $1,481,063  $1,454,588  $1,419,085  $1,351,675  $1,319,069  $1,324,825  Plus:              Debt and finance lease obligations - current 143,112   66,837   45,793   50,678   121,014   121,977   157,325  Operating lease obligations - current (1) 7,758   7,943   8,253   8,470   9,968   14,875   14,697  Debt and finance lease obligations - long-term 91,034   91,139   91,987   92,215   88,761   88,728   89,993  Operating lease obligations - long-term 25,769   27,327   29,422   31,192   32,720   35,124   32,275  Less: Cash and cash equivalents (303,133)   (248,825)   (306,464)   (237,567)   (310,531)   (317,161)   (345,109)   $1,454,340  $1,425,484  $1,323,579  $1,364,073  $1,293,607  $1,262,612  $1,274,006                 


(1)Included in other accrued liabilities on the Condensed Consolidated Balance Sheets.



Risks

  • Risks related to customer delays, changes, cancellations, and forecast inaccuracies which could impact revenue and profitability.
  • Potential negative effects from global trade disputes, tariffs, component shortages, and geopolitical tensions affecting supply chains and demand.
  • Economic risks including sensitivity to fluctuations in end-market demand across aerospace, healthcare, and industrial sectors and exposure to currency and raw material cost volatility.

More from Press Releases

Figure Technology Solutions Reports April 2026 Operating Data May 4, 2026 Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) May 4, 2026 TWFG Insurance Acquires APIA Inc., Expanding Specialty MGA Capabilities and Supporting Long-Term Growth May 4, 2026 Pennant Announces First Quarter 2026 Earnings Release and Call May 4, 2026 Magna Announces 2026 Annual Meeting Results May 4, 2026